ChemoCentryx (CCXI) EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 18.3 | -36.2 | -51.7 | -51.9 | -131.3 | -131.9 | ||
| Changes by years, y/y, % | -146% | -298% | +43% | +0% | +153% | +27.1% | |||
ChemoCentryx. EBITDA US GAAP, bln rub
ChemoCentryx. EBITDA US GAAP, changes, %
ChemoCentryx. EBITDA US GAAP, sum by quarters, bln rub
ChemoCentryx (CCXI) EBITDA US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -37.5 | -20.6 | -44.3 | -37.0 | -30.0 | -131.9 | |
| Changes by years, y/y, % | -279% | -14% | +54% | +28% | -20% | |||
| Changes by quarters, q/q, % | +30% | -45% | +114% | -16% | -19% | |||